Premier Alternatives

BlueWhale Bio

Philadelphia, PA · Founded 2022 · Privately Held (backing)

Developer of a cell-based therapeutic platform intended to overcome bottlenecks in gene therapy manufacturing. BlueWhale Bio is based in Philadelphia, PA and was founded in 2022. It was valued at $52 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $23 million across 1 recorded round; the latest was a $5 million early-stage round in Oct 2025.

PMV mark · valuation
$52.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$23.0M
Last round
Early Stage VC
Oct 2025
How much has BlueWhale Bio raised?
$23.0Macross 1 recorded rounds · Oct 2025 – Oct 2025

Most recently, BlueWhale Bio raised $5.0M in its Early Stage VC (Oct 2025).

Free account
More of BlueWhale Bio with a free account
  • ·Watch BlueWhale Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

BlueWhale Bio round by round

1 rounds
Oct 2025Early Stage VC$5.0MSEC filing▮
1 investors participated

How much has BlueWhale Bio raised?

BlueWhale Bio has raised $23 million in total; 1 of its rounds is on record. The largest on record was a $5 million early-stage round in Oct 2025.

BlueWhale Bio investors

5 investors are on record for BlueWhale Bio, including Hillhouse Investment Group, Marshall Wace, Novalis LifeSciences and Danaher Ventures. The early-stage round in Oct 2025 drew 1 investor.

For fundraisers
Raising for a company like BlueWhale Bio?

5 investors have backed BlueWhale Bio.

See all 5 investors →

Frequently asked about BlueWhale Bio

How much has BlueWhale Bio raised?
BlueWhale Bio has raised $23.0M in total across 1 recorded funding rounds.
When was BlueWhale Bio's last funding round?
BlueWhale Bio's most recent recorded round was Early Stage VC in Oct 2025, raising $5.0M.